KT&G (033780) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Q1 2025 revenue rose 15.4% year-over-year to KRW 1.4911 trillion, with operating profit up 20.7% and adjusted operating profit up 45.1% after excluding one-off wage-related costs, driven by record-high Global CC business performance.
Net income declined 9.7% to KRW 257.9 billion, while EPS fell 4.7% to KRW 2,370.
Implemented a co-CEO system to enhance domestic and overseas business structures and profitability.
Strategic focus on diversifying into modern products, including nicotine pouches, e-vapor, and health functional foods, to secure future growth.
Initiated new product launches, expanded partnerships, and continued global and domestic expansion in next-generation tobacco and health foods.
Financial highlights
Q1 consolidated revenue: KRW 1.4911 trillion (+15.4% YoY); operating profit: KRW 285.6 billion (+20.7% YoY); adjusted operating profit: KRW 343.2 billion (+45.1% YoY).
Net income: KRW 257.9 billion (-9.7% YoY); EBITDA: KRW 354.3 billion (+19.1% YoY); EBITDA margin: 23.8%.
EPS: KRW 2,370 (-4.7% YoY).
Gross profit margin improved to 50.6% from 49.8% YoY; operating profit margin rose to 19.2% from 18.3% YoY.
Cash and cash equivalents at quarter-end: KRW 1,018.7 billion.
Outlook and guidance
No changes to annual guidance; company remains on track to achieve previously communicated targets.
Focus on accelerating global CC growth, expanding modern product categories, and pursuing inorganic growth opportunities.
Full-scale turnaround in health functional foods expected in 2025, with foundational improvements underway in 2024.
Ongoing investment in production capacity, digital transformation, and ESG initiatives.
Targeting further growth in online sales channels and international markets.
Latest events from KT&G
- Record FY24 results with global growth, higher dividends, and aggressive buybacks.033780
Q4 202424 Jun 2026 - Q2 profit jumped on global tobacco gains, but 2024 outlook was cut as HFF and real estate lagged.033780
Q2 202424 Jun 2026 - Record tobacco growth and shareholder returns offset declines in net income and real estate.033780
Q3 202424 Jun 2026 - Record revenue and operating profit growth, but net income fell; dividends and buybacks increased.033780
Q2 202524 Jun 2026 - Record revenue and profit, net income up 73.4%, guidance raised, global expansion planned.033780
Q3 202524 Jun 2026 - Record Q1 revenue and profit growth driven by global tobacco and health foods, with stronger dividends ahead.033780
Q1 202622 Jun 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026 - Accelerated global growth, record shareholder returns, and new Altria partnership drive expansion.033780
Investor Day 2025 Presentation23 Sep 2025